Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
about
Metabolism and possible health effects of aluminumImpact of effects of acid precipitation on toxicity of metalsWater content of aluminum, dialysis dementia, and osteomalacia.Aluminum and chronic renal failure: sources, absorption, transport, and toxicity.Do oral aluminium phosphate binders cause accumulation of aluminium to toxic levels?No association between the aluminium content of trabecular bone and bone density, mass or size of the proximal femur in elderly men and womenEvidence of aluminium accumulation in aluminium welders.Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia.Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.Accumulation of metals and minerals from phosphate binders.Parathyroidectomy for hyperparathyroidism associated with renal disease.Toxic substances and the nervous system: the role of clinical observation.Osteomalacia and chronic renal failure.Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy.Bone histoquantitative findings and histochemical staining reactions for aluminium in chronic renal failure patients treated with haemodialysis fluids containing high and low concentrations of aluminiumChanges in bone histoquantitative parameters and histochemical staining reactions for aluminium in a group of patients with chronic renal failure following a reduction in the aluminium concentration of the haemodialysis fluid.Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water.Different approaches to the study of chelating agents for iron and aluminium overload pathologies.Iron-based phosphate binders--a new element in management of hyperphosphatemia.Recent developments in aluminum toxicology.Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.Methods for the determination of trace aluminium contamination in dialysis fluids.Aluminum and bone disorders: with specific reference to aluminum contamination of infant nutrients.Aluminum toxicity.The clinical biochemistry of aluminum.Water purification and the incidence of fractures in patients receiving home haemodialysis supervised by a single centre: evidence for "safe" upper limit of aluminium in water.Aluminium hydroxide intake: real risk of aluminium toxicity.Radiography of healing dialysis osteodystrophy.Reconsidering the importance of long-term low-level aluminum exposure in renal failure patients.The evaluation of novel mixed metal hydroxy-carbonates as phosphate binders: an in-vivo study in the rat.Effects of combined exposure to aluminium and ethanol on aluminium body burden and some neuronal, hepatic and haematopoietic biochemical variables in the rat.Elevation of serum aluminum in humans on a two-day sucralfate regimen.Parathyroidectomy in uraemic hyperparathyroidism: a clinical studyCalcium carbonate 1250 mg/1260 mg: an effective phosphate binder
P2860
Q28389111-53D70D1F-698E-42DC-BC6F-00A1D446C200Q28390907-FE194FDE-36A6-4674-B7A9-CB1B2C8E18A2Q28390919-C97A0FA4-D9F5-4A23-AFED-D0F68DDC5D2DQ30459816-046CCD11-52C4-44D8-B2F5-AA52113332A7Q31033697-9E05A2BB-8A54-44F0-BE31-BBC2E27D2215Q33254998-EA1C8A87-178D-42FB-8DC3-6452E409C194Q33634624-326065E7-77B1-4F8A-9770-840E6D337FC4Q34599720-611C02BD-0D2B-4220-A076-896EC201FF7AQ35021546-9B262D6C-3610-480D-9A39-C7846F7BD1E2Q35854025-9372682C-60D2-4DF7-9552-91431A2D854AQ36098773-15A1F5FD-F8B3-4A8A-9DB4-841F2A532033Q36820257-2E647914-540E-40C8-BBAE-E41594C95061Q37004860-27992C55-482F-4EC1-936D-9B186091AD0EQ37094948-C5DCB110-4CC7-4B14-88C7-01C7E4131CA9Q37164231-F6FF492B-5EE5-4907-90DD-A3D6A87467FAQ37176485-20934E6F-16B4-4FBF-B6B7-6119F90687A8Q37182320-8036B8D1-F8C8-46BE-AFBC-8CACD4E0ED26Q37404092-0A86A591-34CD-4800-914A-397481E3D86EQ38003480-09439D6F-4400-4434-B7DD-FD25BB78FB64Q38055398-FC51FED3-7AA9-49ED-8519-DFB71F40344DQ38295285-62300BF7-7D61-405D-B394-728CD7E218D6Q38620775-06312DB6-1BB5-4348-985E-45ACFF3AAC2EQ39377975-5B6613C4-7E3D-4B14-856B-83E85CDE96B8Q39567816-212A674D-186A-43A2-A1D6-0CB3DE9D2E7DQ39652030-9694ED0F-CD07-449D-B321-72FBAF8D0C72Q40211987-070372AE-7B76-4AE1-B559-9D0EDAA3DB41Q40307432-B18F707A-C3A9-432B-A91B-A9323F1CE8E9Q41888973-252D35B3-F2F8-43DA-A596-8C8CA73CBFA1Q42790955-1AC3A8B3-731E-467D-AAE9-16FD3258436CQ43323154-7A9A0F59-ABD3-4C9A-886B-07622455878EQ43530564-8B315062-FBDB-46B0-B641-C0052B9F7C2CQ43600008-9EECD85A-DEB3-4A95-834A-22BEE1D15720Q44216009-867FC47D-07CF-4A5D-A500-6EDBA46D44BBQ44319711-57323A66-9E73-4082-843F-BC4872C93D69Q57226416-B117CA7F-62F6-45BD-82D3-D25D96C22FE1Q57226832-F85EA100-FFD1-4670-A838-329831129A2D
P2860
Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Fracturing dialysis osteodystr ...... hy. An epidemiological survey.
@en
Fracturing dialysis osteodystr ...... hy. An epidemiological survey.
@nl
type
label
Fracturing dialysis osteodystr ...... hy. An epidemiological survey.
@en
Fracturing dialysis osteodystr ...... hy. An epidemiological survey.
@nl
altLabel
FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHY
@en
prefLabel
Fracturing dialysis osteodystr ...... hy. An epidemiological survey.
@en
Fracturing dialysis osteodystr ...... hy. An epidemiological survey.
@nl
P2093
P1433
P1476
Fracturing dialysis osteodystr ...... hy. An epidemiological survey.
@en
P2093
I S Parkinson
R W Fawcett
P304
P356
10.1016/S0140-6736(79)90883-3
P407
P577
1979-02-01T00:00:00Z